Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mimedx Group Inc (MDXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 383,071
  • Shares Outstanding, K 111,035
  • Annual Sales, $ 245,020 K
  • Annual Income, $ 11,970 K
  • 60-Month Beta 2.23
  • Price/Sales 1.40
  • Price/Cash Flow N/A
  • Price/Book 2.66
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/03/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.7600 +28.62%
on 02/27/19
3.9800 -10.80%
on 03/19/19
+0.5300 (+17.55%)
since 02/26/19
3-Month
1.3200 +168.94%
on 12/27/18
3.9800 -10.80%
on 03/19/19
+2.0700 (+139.86%)
since 12/26/18
52-Week
0.9500 +273.68%
on 12/06/18
9.9900 -64.46%
on 05/23/18
-3.7000 (-51.03%)
since 03/26/18

Most Recent Stories

More News
Delisting of Securities of Altus Midstream Company Warrant, MiMedx Group, Inc., Waitr Holdings Inc. Warrant, Eco-Stim Energy Solutions, Inc., and Concrete Pumping Holdings, Inc. Warrant from The Nasdaq Stock Market

The Nasdaq Stock Market announced today that it will delist the warrant of Altus Midstream Company. Altus Midstream Company's warrant was suspended on December 20, 2018 and has not traded on Nasdaq since...

MDXG : 3.5500 (+2.90%)
NDAQ : 85.82 (+1.07%)
ESES : 0.0200 (-33.33%)
Prescience Point Capital Management Issues Positive Report on MiMedx Group Inc. (OTC: MDXG)

-- MDXG has zero debt and a highly flexible cost structure, which should allow it to easily generate enough liquidity to overcome recent challenges.

MDXG : 3.5500 (+2.90%)
PTCI : 0.4000 (unch)
HMS Hires Robert P. Borchert as New Investor Relations Officer

HMS Holdings Corp (Nasdaq:HMSY) today announced that Robert P. Borchert has joined the Company as Senior Vice President, Investor Relations. He succeeds Dennis Oakes, who is retiring after more than four...

MDXG : 3.5500 (+2.90%)
ABCO : 53.83 (+0.09%)
HMSY : 29.15 (-5.66%)
After Yesterday's Rally of 7.45% Shares Could Potentially Pullback

Mimedx Group Inc (NASDAQ:MDXG) traded in a range yesterday that spanned from a low of $1.55 to a high of $1.73. Yesterday, the shares gained 7.5%, which took the trading range above the 3-day high of...

MDXG : 3.5500 (+2.90%)
Today's Research Reports on Trending Tickers: MiMedx Group and Tandem Diabetes Care

NEW YORK, NY / ACCESSWIRE / December 12, 2018 / U.S. equities finished lower on Tuesday after bouncing between the red and green territory. The stocks gained more than 1% across the board on improving...

MDXG : 3.5500 (+2.90%)
MiMedx Announces Resignation Of Outside Auditor

MiMedx Group, Inc. (OTC PINK: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that on December 4, 2018, Ernst & Young LLP informed the Company's Audit...

MDXG : 3.5500 (+2.90%)
MiMedx Announces Leadership Changes And Promotions

MiMedx Group, Inc. (OTC PINK: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced certain leadership changes and promotions in conjunction with its plans...

MDXG : 3.5500 (+2.90%)
MiMedx Announces Organizational Realignment Program

MiMedx Group, Inc. (OTC PINK: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced its plans to implement a broad-based organizational realignment, cost reduction...

MDXG : 3.5500 (+2.90%)
MiMedx To Participate In The Bank of America Merrill Lynch Healthcare Conference On May 16, 2018

MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced today that it will participate in the Bank of America Merrill Lynch 2018 Healthcare...

MDXG : 3.5500 (+2.90%)
MiMedx Comments On Matters Related To Former VA Employees

MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today commented on the indictment filed in the United States District Court for the District...

MDXG : 3.5500 (+2.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade MDXG with:

Key Turning Points

2nd Resistance Point 3.8167
1st Resistance Point 3.6833
Last Price 3.5500
1st Support Level 3.4133
2nd Support Level 3.2767

See More

52-Week High 9.9900
Fibonacci 61.8% 6.5367
Fibonacci 50% 5.4700
Fibonacci 38.2% 4.4033
Last Price 3.5500
52-Week Low 0.9500

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar